Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (231-240 of 276) with videos related to

Pageof 28
Sort By:
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
JCO Precision Oncology|September 2, 2025
Immunotherapy Resistance in Lethal Prepubescent Spitz Melanoma With <i>TERT</i> Promoter VariantAlissa Groisser, Liny John, A Yasmine Kirkorian, et al.
Plos One|March 22, 2016
High-Throughput Microdissection for Next-Generation SequencingAvi Z Rosenberg, Michael D Armani, Patricia A Fetsch, et al.
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II StudyAnish Thomas, Rasa Vilimas, Christopher Trindade, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Acta Neuropathologica|February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
The Journal of Experimental Medicine|November 7, 2012
Congenital B cell lymphocytosis explained by novel germline CARD11 mutationsAndrew L Snow, Wenming Xiao, Jeffrey R Stinson, et al.
Science (New York, N.Y.)|September 21, 2002
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesMark E Dudley, John R Wunderlich, Paul F Robbins, et al.
Cancers|July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung AdenocarcinomaChul Kim, Liqiang Xi, Constance M Cultraro, et al.
Pageof 28

Showing results (231-240 of 276) with videos related to

Sort By:
Pageof 28
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
JCO Precision Oncology|September 2, 2025
Immunotherapy Resistance in Lethal Prepubescent Spitz Melanoma With <i>TERT</i> Promoter VariantAlissa Groisser, Liny John, A Yasmine Kirkorian, et al.
Plos One|March 22, 2016
High-Throughput Microdissection for Next-Generation SequencingAvi Z Rosenberg, Michael D Armani, Patricia A Fetsch, et al.
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II StudyAnish Thomas, Rasa Vilimas, Christopher Trindade, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Acta Neuropathologica|February 1, 2022
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Drew Pratt, Zied Abdullaev, Antonios Papanicolau-Sengos, et al.
The Journal of Experimental Medicine|November 7, 2012
Congenital B cell lymphocytosis explained by novel germline CARD11 mutationsAndrew L Snow, Wenming Xiao, Jeffrey R Stinson, et al.
Science (New York, N.Y.)|September 21, 2002
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesMark E Dudley, John R Wunderlich, Paul F Robbins, et al.
Cancers|July 20, 2021
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung AdenocarcinomaChul Kim, Liqiang Xi, Constance M Cultraro, et al.
Pageof 28